In addition, gemcitabine seems to exert indirect immunogenic effects inducing tumor cell apoptosis that increase antigen cross-presentation, and enhancing CD8 + T cell and natural killer (NK) cell-mediated anti-tumor immunity through elimination of myeloid-derived suppressor cells (MDSCs) and regulatory T cells [12–16]. The gene discussed is CD8A; the disease is neoplasm.